Illinois General Assembly - Full Text of SB2391
Illinois General Assembly

Previous General Assemblies

Full Text of SB2391  94th General Assembly

SB2391ham001 94TH GENERAL ASSEMBLY

Judiciary II - Criminal Law Committee

Filed: 3/28/2006

 

 


 

 


 
09400SB2391ham001 LRB094 15742 RLC 57326 a

1
AMENDMENT TO SENATE BILL 2391

2     AMENDMENT NO. ______. Amend Senate Bill 2391 on page 1, by
3 inserting after line 3 the following:
 
4     "Section 2. The Illinois Controlled Substances Act is
5 amended by changing Section 312 as follows:
 
6     (720 ILCS 570/312)  (from Ch. 56 1/2, par. 1312)
7     Sec. 312. Requirements for dispensing controlled
8 substances.
9     (a) A practitioner, in good faith, may dispense a Schedule
10 II controlled substance, which is a narcotic drug listed in
11 Section 206 of this Act; or which contains any quantity of
12 amphetamine or methamphetamine, their salts, optical isomers
13 or salts of optical isomers; phenmetrazine and its salts; or
14 pentazocine; and Schedule III, IV, or V controlled substances
15 to any person upon a written prescription of any prescriber,
16 dated and signed by the person prescribing on the day when
17 issued and bearing the name and address of the patient for
18 whom, or the owner of the animal for which the controlled
19 substance is dispensed, and the full name, address and registry
20 number under the laws of the United States relating to
21 controlled substances of the prescriber, if he is required by
22 those laws to be registered. If the prescription is for an
23 animal it shall state the species of animal for which it is
24 ordered. The practitioner filling the prescription shall write

 

 

09400SB2391ham001 - 2 - LRB094 15742 RLC 57326 a

1 the date of filling and his own signature on the face of the
2 written prescription. The written prescription shall be
3 retained on file by the practitioner who filled it or pharmacy
4 in which the prescription was filled for a period of 2 years,
5 so as to be readily accessible for inspection or removal by any
6 officer or employee engaged in the enforcement of this Act.
7 Whenever the practitioner's or pharmacy's copy of any
8 prescription is removed by an officer or employee engaged in
9 the enforcement of this Act, for the purpose of investigation
10 or as evidence, such officer or employee shall give to the
11 practitioner or pharmacy a receipt in lieu thereof. A
12 prescription for a Schedule II controlled substance shall not
13 be filled more than 7 days after the date of issuance. A
14 written prescription for Schedule III, IV or V controlled
15 substances shall not be filled or refilled more than 6 months
16 after the date thereof or refilled more than 5 times unless
17 renewed, in writing, by the prescriber.
18     (b) In lieu of a written prescription required by this
19 Section, a pharmacist, in good faith, may dispense Schedule
20 III, IV, or V substances to any person either upon receiving a
21 facsimile of a written, signed prescription transmitted by the
22 prescriber or the prescriber's agent or upon a lawful oral
23 prescription of a prescriber which oral prescription shall be
24 reduced promptly to writing by the pharmacist and such written
25 memorandum thereof shall be dated on the day when such oral
26 prescription is received by the pharmacist and shall bear the
27 full name and address of the ultimate user for whom, or of the
28 owner of the animal for which the controlled substance is
29 dispensed, and the full name, address, and registry number
30 under the law of the United States relating to controlled
31 substances of the prescriber prescribing if he is required by
32 those laws to be so registered, and the pharmacist filling such
33 oral prescription shall write the date of filling and his own
34 signature on the face of such written memorandum thereof. The

 

 

09400SB2391ham001 - 3 - LRB094 15742 RLC 57326 a

1 facsimile copy of the prescription or written memorandum of the
2 oral prescription shall be retained on file by the proprietor
3 of the pharmacy in which it is filled for a period of not less
4 than two years, so as to be readily accessible for inspection
5 by any officer or employee engaged in the enforcement of this
6 Act in the same manner as a written prescription. The facsimile
7 copy of the prescription or oral prescription and the written
8 memorandum thereof shall not be filled or refilled more than 6
9 months after the date thereof or be refilled more than 5 times,
10 unless renewed, in writing, by the prescriber.
11     (c) Except for any non-prescription targeted
12 methamphetamine precursor regulated by as defined in the
13 Methamphetamine Precursor Control Act, a controlled substance
14 included in Schedule V shall not be distributed or dispensed
15 other than for a medical purpose and not for the purpose of
16 evading this Act, and then:
17         (1) only personally by a person registered to dispense
18     a Schedule V controlled substance and then only to his
19     patients, or
20         (2) only personally by a pharmacist, and then only to a
21     person over 21 years of age who has identified himself to
22     the pharmacist by means of 2 positive documents of
23     identification.
24         (3) the dispenser shall record the name and address of
25     the purchaser, the name and quantity of the product, the
26     date and time of the sale, and the dispenser's signature.
27         (4) no person shall purchase or be dispensed more than
28     120 milliliters or more than 120 grams of any Schedule V
29     substance which contains codeine, dihydrocodeine, or any
30     salts thereof, or ethylmorphine, or any salts thereof, in
31     any 96 hour period. The purchaser shall sign a form,
32     approved by the Department of Professional Regulation,
33     attesting that he has not purchased any Schedule V
34     controlled substances within the immediately preceding 96

 

 

09400SB2391ham001 - 4 - LRB094 15742 RLC 57326 a

1     hours.
2         (5) a copy of the records of sale, including all
3     information required by paragraph (3), shall be forwarded
4     to the Department of Professional Regulation at its
5     principal office by the 15th day of the following month.
6         (6) all records of purchases and sales shall be
7     maintained for not less than 2 years.
8         (7) no person shall obtain or attempt to obtain within
9     any consecutive 96 hour period any Schedule V substances of
10     more than 120 milliliters or more than 120 grams containing
11     codeine, dihydrocodeine or any of its salts, or
12     ethylmorphine or any of its salts. Any person obtaining any
13     such preparations or combination of preparations in excess
14     of this limitation shall be in unlawful possession of such
15     controlled substance.
16         (8) a person qualified to dispense controlled
17     substances under this Act and registered thereunder shall
18     at no time maintain or keep in stock a quantity of Schedule
19     V controlled substances defined and listed in Section 212
20     (b) (1), (2) or (3) in excess of 4.5 liters for each
21     substance; a pharmacy shall at no time maintain or keep in
22     stock a quantity of Schedule V controlled substances as
23     defined in excess of 4.5 liters for each substance, plus
24     the additional quantity of controlled substances necessary
25     to fill the largest number of prescription orders filled by
26     that pharmacy for such controlled substances in any one
27     week in the previous year. These limitations shall not
28     apply to Schedule V controlled substances which Federal law
29     prohibits from being dispensed without a prescription.
30         (9) no person shall distribute or dispense butyl
31     nitrite for inhalation or other introduction into the human
32     body for euphoric or physical effect.
33     (d) Every practitioner shall keep a record of controlled
34 substances received by him and a record of all such controlled

 

 

09400SB2391ham001 - 5 - LRB094 15742 RLC 57326 a

1 substances administered, dispensed or professionally used by
2 him otherwise than by prescription. It shall, however, be
3 sufficient compliance with this paragraph if any practitioner
4 utilizing controlled substances listed in Schedules III, IV and
5 V shall keep a record of all those substances dispensed and
6 distributed by him other than those controlled substances which
7 are administered by the direct application of a controlled
8 substance, whether by injection, inhalation, ingestion, or any
9 other means to the body of a patient or research subject. A
10 practitioner who dispenses, other than by administering, a
11 controlled substance in Schedule II, which is a narcotic drug
12 listed in Section 206 of this Act, or which contains any
13 quantity of amphetamine or methamphetamine, their salts,
14 optical isomers or salts of optical isomers, pentazocine, or
15 methaqualone shall do so only upon the issuance of a written
16 prescription blank by a prescriber.
17     (e) Whenever a manufacturer distributes a controlled
18 substance in a package prepared by him, and whenever a
19 wholesale distributor distributes a controlled substance in a
20 package prepared by him or the manufacturer, he shall securely
21 affix to each package in which that substance is contained a
22 label showing in legible English the name and address of the
23 manufacturer, the distributor and the quantity, kind and form
24 of controlled substance contained therein. No person except a
25 pharmacist and only for the purposes of filling a prescription
26 under this Act, shall alter, deface or remove any label so
27 affixed.
28     (f) Whenever a practitioner dispenses any controlled
29 substance except a non-prescription targeted methamphetamine
30 precursor regulated by as defined in the Methamphetamine
31 Precursor Control Act, he shall affix to the container in which
32 such substance is sold or dispensed, a label indicating the
33 date of initial filling, the practitioner's name and address,
34 the name of the patient, the name of the prescriber, the

 

 

09400SB2391ham001 - 6 - LRB094 15742 RLC 57326 a

1 directions for use and cautionary statements, if any, contained
2 in any prescription or required by law, the proprietary name or
3 names or the established name of the controlled substance, and
4 the dosage and quantity, except as otherwise authorized by
5 regulation by the Department of Professional Regulation. No
6 person shall alter, deface or remove any label so affixed.
7     (g) A person to whom or for whose use any controlled
8 substance has been prescribed or dispensed by a practitioner,
9 or other persons authorized under this Act, and the owner of
10 any animal for which such substance has been prescribed or
11 dispensed by a veterinarian, may lawfully possess such
12 substance only in the container in which it was delivered to
13 him by the person dispensing such substance.
14     (h) The responsibility for the proper prescribing or
15 dispensing of controlled substances is upon the prescriber and
16 the responsibility for the proper filling of a prescription for
17 controlled substance drugs rests with the pharmacist. An order
18 purporting to be a prescription issued to any individual, which
19 is not in the regular course of professional treatment nor part
20 of an authorized methadone maintenance program, nor in
21 legitimate and authorized research instituted by any
22 accredited hospital, educational institution, charitable
23 foundation, or federal, state or local governmental agency, and
24 which is intended to provide that individual with controlled
25 substances sufficient to maintain that individual's or any
26 other individual's physical or psychological addiction,
27 habitual or customary use, dependence, or diversion of that
28 controlled substance is not a prescription within the meaning
29 and intent of this Act; and the person issuing it, shall be
30 subject to the penalties provided for violations of the law
31 relating to controlled substances.
32     (i) A prescriber shall not preprint or cause to be
33 preprinted a prescription for any controlled substance; nor
34 shall any practitioner issue, fill or cause to be issued or

 

 

09400SB2391ham001 - 7 - LRB094 15742 RLC 57326 a

1 filled, a preprinted prescription for any controlled
2 substance.
3     (j) No person shall manufacture, dispense, deliver,
4 possess with intent to deliver, prescribe, or administer or
5 cause to be administered under his direction any anabolic
6 steroid, for any use in humans other than the treatment of
7 disease in accordance with the order of a physician licensed to
8 practice medicine in all its branches for a valid medical
9 purpose in the course of professional practice. The use of
10 anabolic steroids for the purpose of hormonal manipulation that
11 is intended to increase muscle mass, strength or weight without
12 a medical necessity to do so, or for the intended purpose of
13 improving physical appearance or performance in any form of
14 exercise, sport, or game, is not a valid medical purpose or in
15 the course of professional practice.
16 (Source: P.A. 94-694, eff. 1-15-06.)"; and
 
17 on page 14, by inserting after line 1 the following:
 
18     "Section 10. The Methamphetamine Precursor Control Act is
19 amended by changing Sections 5, 10, 15, 20, 25, and 35 and by
20 adding Section 60 as follows:
 
21     (720 ILCS 648/5)
22     Sec. 5. Purpose. The purpose of this Act is to reduce the
23 harm that methamphetamine manufacturing and manufacturers are
24 inflicting on individuals, families, communities, first
25 responders, the economy, and the environment in Illinois, by
26 making it more difficult for persons engaged in the unlawful
27 manufacture of methamphetamine and related activities to
28 obtain methamphetamine's essential ingredient, ephedrine or
29 pseudoephedrine. It is the intent of the General Assembly that
30 this Act operate in tandem with and be interpreted as
31 consistent with federal laws and regulations relating to the

 

 

09400SB2391ham001 - 8 - LRB094 15742 RLC 57326 a

1 subject matter of this Act to the greatest extent possible.
2 (Source: P.A. 94-694, eff. 1-15-06.)
 
3     (720 ILCS 648/10)
4     Sec. 10. Definitions. In this Act:
5     "Administer" or "administration" has the meaning provided
6 in Section 102 of the Illinois Controlled Substances Act.
7     "Agent" has the meaning provided in Section 102 of the
8 Illinois Controlled Substances Act.
9     "Convenience package" means any package that contains 360
10 milligrams or less of ephedrine or pseudoephedrine, their salts
11 or optical isomers, or salts of optical isomers in liquid or
12 liquid-filled capsule form.
13     "Deliver" has the meaning provided in Section 102 of the
14 Illinois Controlled Substances Act.
15     "Dispense" has the meaning provided in Section 102 of the
16 Illinois Controlled Substances Act.
17     "Distribute" has the meaning provided in Section 102 of the
18 Illinois Controlled Substances Act.
19     "List I chemical" has the meaning provided in 21 U.S.C.
20 Section 802.
21     "Methamphetamine precursor" has the meaning provided in
22 Section 10 of the Methamphetamine Control and Community
23 Protection Act.
24     "Package" means an item packaged and marked for retail sale
25 that is not designed to be further broken down or subdivided
26 for the purpose of retail sale.
27     "Pharmacist" has the meaning provided in Section 102 of the
28 Illinois Controlled Substances Act.
29     "Pharmacy" has the meaning provided in Section 102 of the
30 Illinois Controlled Substances Act.
31     "Practitioner" has the meaning provided in Section 102 of
32 the Illinois Controlled Substances Act.
33     "Prescriber" has the meaning provided in Section 102 of the

 

 

09400SB2391ham001 - 9 - LRB094 15742 RLC 57326 a

1 Illinois Controlled Substances Act.
2     "Prescription" has the meaning provided in Section 102 of
3 the Illinois Controlled Substances Act.
4     "Readily retrievable" has the meaning provided in 21 C.F.R.
5 part 1300.
6     "Retail distributor" means a grocery store, general
7 merchandise store, drug store, other merchandise store, or
8 other entity or person whose activities as a distributor
9 relating to drug products containing targeted methamphetamine
10 precursor are limited exclusively or almost exclusively to
11 sales for personal use by an ultimate user, both in number of
12 sales and volume of sales, either directly to walk-in customers
13 or in face-to-face transactions by direct sales.
14     "Sales employee" means any employee or agent, other than a
15 pharmacist or pharmacy technician who works exclusively or
16 almost exclusively behind a pharmacy counter, who at any time
17 (a) operates a cash register at which targeted packages may be
18 sold, (b) works at or behind a pharmacy counter, (c) stocks
19 shelves containing targeted packages, or (c) (d) trains or
20 supervises any other employee or agent who engages in any of
21 the preceding activities.
22     "Single retail transaction" means a sale by a retail
23 distributor to a specific customer at a specific time.
24     "Targeted methamphetamine precursor" means any compound,
25 mixture, or preparation that contains any detectable quantity
26 of ephedrine or pseudoephedrine, their salts or optical
27 isomers, or salts of optical isomers.
28     "Targeted package" means a package, including a
29 convenience package, containing any amount of targeted
30 methamphetamine precursor.
31     "Ultimate user" has the meaning provided in Section 102 of
32 the Illinois Controlled Substances Act.
33 (Source: P.A. 94-694, eff. 1-15-06.)
 

 

 

09400SB2391ham001 - 10 - LRB094 15742 RLC 57326 a

1     (720 ILCS 648/15)
2     Sec. 15. Basic provisions.
3     (a) No targeted methamphetamine precursor shall be
4 purchased, received, or otherwise acquired in any manner other
5 than that described in Section 20 of this Act.
6     (b) No targeted methamphetamine precursor shall be
7 knowingly administered, dispensed, or distributed for any
8 purpose other than a medical purpose.
9     (c) No targeted methamphetamine precursor shall be
10 knowingly administered, dispensed, or distributed for the
11 purpose of violating or evading this Act, the Illinois
12 Controlled Substances Act, or the Methamphetamine Control and
13 Community Protection Act.
14     (d) No targeted methamphetamine precursor shall be
15 administered, dispensed, or distributed with knowledge that it
16 will be used to manufacture methamphetamine or with reckless
17 disregard of its likely use to manufacture methamphetamine.
18     (e) No targeted methamphetamine precursor shall be
19 administered, dispensed, or distributed except by:
20         (1) a pharmacist pursuant to the valid order of a
21     prescriber;
22         (2) any other practitioner authorized to do so by the
23     Illinois Controlled Substances Act;
24         (3) a drug abuse treatment program, pursuant to
25     subsection (d) of Section 313 of the Illinois Controlled
26     Substances Act;
27         (4) a pharmacy pursuant to Section 25 of this Act;
28         (5) a retail distributor pursuant to Sections 30 and 35
29     of this Act; or
30         (6) a distributor authorized by the Drug Enforcement
31     Administration to distribute bulk quantities of a list I
32     chemical under the federal Controlled Substances Act and
33     corresponding regulations, or the employee or agent of such
34     a distributor acting in the normal course of business.

 

 

09400SB2391ham001 - 11 - LRB094 15742 RLC 57326 a

1     (f) Notwithstanding any provision of this Act to the
2 contrary, it is lawful for persons to provide small quantities
3 of targeted methamphetamine precursors to immediate family or
4 household members for legitimate medical purposes, and it is
5 lawful for persons to receive small quantities of targeted
6 methamphetamine precursors from immediate family or household
7 members for legitimate medical purposes.
8 (Source: P.A. 94-694, eff. 1-15-06.)
 
9     (720 ILCS 648/20)
10     Sec. 20. Restrictions on purchase, receipt, or
11 acquisition.
12     (a) Except as provided in subsection (e) of this Section,
13 any person 18 years of age or older wishing to purchase,
14 receive, or otherwise acquire a targeted methamphetamine
15 precursor shall, prior to taking possession of the targeted
16 methamphetamine precursor:
17         (1) provide a driver's license or other
18     government-issued identification showing the person's
19     name, date of birth, and photograph; and
20         (2) sign a log documenting the name and address of the
21     person, date and time of the transaction, and brand and
22     product name and total quantity distributed of ephedrine or
23     pseudoephedrine, their salts, or optical isomers, or salts
24     of optical isomers.
25     (b) Except as provided in subsection (e) of this Section,
26 no person shall knowingly purchase, receive, or otherwise
27 acquire, within any 30-day period products containing more than
28 a total of 7,500 milligrams of ephedrine or pseudoephedrine,
29 their salts or optical isomers, or salts of optical isomers.
30     (c) Except as provided in subsections (d) and (e) of this
31 Section, no person shall knowingly purchase, receive, or
32 otherwise acquire more than 2 targeted packages in a single
33 retail transaction.

 

 

09400SB2391ham001 - 12 - LRB094 15742 RLC 57326 a

1     (d) Except as provided in subsection (e) of this Section,
2 no person shall knowingly purchase, receive, or otherwise
3 acquire more than one convenience package from a retail
4 location other than a pharmacy counter in a 24-hour period.
5     (e) This Section shall not apply to any person who
6 purchases, receives, or otherwise acquires a targeted
7 methamphetamine precursor for the purpose of dispensing,
8 distributing, or administering it in a lawful manner described
9 in subsection (e) of Section 15 of this Act.
10 (Source: P.A. 94-694, eff. 1-15-06.)
 
11     (720 ILCS 648/25)
12     Sec. 25. Pharmacies.
13     (a) No targeted methamphetamine precursor may be knowingly
14 distributed through a pharmacy, including a pharmacy located
15 within, owned by, operated by, or associated with a retail
16 distributor unless all terms of this Section are satisfied.
17     (b) Any targeted methamphetamine precursor other than a
18 convenience package or a liquid, including but not limited to
19 any targeted methamphetamine precursor in liquid-filled
20 capsules, The targeted methamphetamine precursor shall: (1) be
21 packaged in blister packs, with each blister containing not
22 more than 2 dosage units, or when the use of blister packs is
23 technically infeasible, in unit dose packets. Each targeted
24 package shall ; and (2) contain no more than 3,000 milligrams of
25 ephedrine or pseudoephedrine, their salts or optical isomers,
26 or salts of optical isomers.
27     (c) The targeted methamphetamine precursor shall be stored
28 behind the pharmacy counter and distributed by a pharmacist or
29 pharmacy technician licensed under the Pharmacy Practice Act of
30 1987.
31     (d) Any retail distributor operating a pharmacy, and any
32 pharmacist or pharmacy technician involved in the transaction
33 or transactions, shall ensure that any person purchasing,

 

 

09400SB2391ham001 - 13 - LRB094 15742 RLC 57326 a

1 receiving, or otherwise acquiring the targeted methamphetamine
2 precursor complies with subsection (a) of Section 20 of this
3 Act.
4     (e) Any retail distributor operating a pharmacy, and any
5 pharmacist or pharmacy technician involved in the transaction
6 or transactions, shall verify that:
7         (1) The person purchasing, receiving, or otherwise
8     acquiring the targeted methamphetamine precursor is 18
9     years of age or older and resembles the photograph of the
10     person on the government-issued identification presented
11     by the person; and
12         (2) The name entered into the log referred to in
13     subsection (a) of Section 20 of this Act corresponds to the
14     name on the government-issued identification presented by
15     the person.
16     (f) The logs referred to in subsection (a) of Section 20 of
17 this Act shall be kept confidential, maintained for not less
18 than 2 years, and made available for inspection and copying by
19 any law enforcement officer upon request of that officer. These
20 logs may be kept in an electronic format if they include all
21 the information specified in subsection (a) of Section 20 of
22 this Act in a manner that is readily retrievable and
23 reproducible in hard-copy format.
24     (g) No retail distributor operating a pharmacy, and no
25 pharmacist or pharmacy technician, shall knowingly distribute
26 any targeted methamphetamine precursor to any person under 18
27 years of age.
28     (h) No retail distributor operating a pharmacy, and no
29 pharmacist or pharmacy technician, shall knowingly distribute
30 to a single person in any 24-hour period more than one
31 convenience package.
32     (i) Except as provided in subsection (h) of this Section,
33 no
34     (h) No retail distributor operating a pharmacy, and no

 

 

09400SB2391ham001 - 14 - LRB094 15742 RLC 57326 a

1 pharmacist or pharmacy technician, shall knowingly distribute
2 to a single person more than 2 targeted packages in a single
3 retail transaction.
4     (i) (j) No retail distributor operating a pharmacy, and no
5 pharmacist or pharmacy technician, shall knowingly distribute
6 to a single person in any 30-day period products containing
7 more than a total of 7,500 milligrams of ephedrine or
8 pseudoephedrine, their salts or optical isomers, or salts of
9 optical isomers.
10     (j) A pharmacist or pharmacy technician may distribute a
11 targeted methamphetamine precursor to a person who is without a
12 form of identification specified in paragraph (1) of subsection
13 (a) of Section 20 of this Act only if all other provisions of
14 this Act are followed and either:
15         (1) the person presents a driver's license issued
16     without a photograph by the State of Illinois pursuant to
17     the Illinois Administrative Code, Title 92, Section
18     1030.90(b)(1) or 1030.90(b)(2); or
19         (2) the person is known to the pharmacist or pharmacy
20     technician, the person presents some form of
21     identification, and the pharmacist or pharmacy technician
22     reasonably believes that the targeted methamphetamine
23     precursor will be used for a legitimate medical purpose and
24     not to manufacture methamphetamine.
25     (k) When a pharmacist or pharmacy technician distributes a
26 targeted methamphetamine precursor to a person according to the
27 procedures set forth in this Act, and the pharmacist or
28 pharmacy technician does not have access to a working cash
29 register at the pharmacy counter, the pharmacist or pharmacy
30 technician may instruct the person to pay for the targeted
31 methamphetamine precursor at a cash register located elsewhere
32 in the retail establishment, whether that register is operated
33 by a pharmacist, pharmacy technician, or other employee or
34 agent of the retail establishment.

 

 

09400SB2391ham001 - 15 - LRB094 15742 RLC 57326 a

1 (Source: P.A. 94-694, eff. 1-15-06.)
 
2     (720 ILCS 648/35)
3     Sec. 35. Retail distributors; training requirements.
4     (a) Every retail distributor of any targeted
5 methamphetamine precursor shall train each sales employee on
6 the topics listed on the certification form described in
7 subsection (b) of this Section. This training may be conducted
8 by a live trainer or by means of a computer-based training
9 program. This training shall be completed within 30 days of the
10 effective date of this Act or within 30 days of the date that
11 each sales employee begins working for the retail distributor,
12 whichever of these 2 dates comes later.
13     (b) Immediately after training each sales employee as
14 required in subsection (a) of this Section, every retail
15 distributor of any targeted methamphetamine precursor shall
16 have each sales employee read, sign, and date a certification
17 containing the following language:
18         (1) My name is (insert name of employee) and I am an
19     employee of (insert name of business) at (insert street
20     address).
21         (2) I understand that in Illinois there are laws
22     governing the sale of certain over-the-counter medications
23     that contain a chemical called ephedrine or a second
24     chemical called pseudoephedrine. Medications that are
25     subject to these laws are called "targeted methamphetamine
26     precursors".
27         (3) I understand that "targeted methamphetamine
28     precursors" can be used to manufacture the illegal and
29     dangerous drug methamphetamine and that methamphetamine is
30     causing great harm to individuals, families, communities,
31     the economy, and the environment throughout Illinois.
32         (4) I understand that under Illinois law, unless they
33     are at a pharmacy counter, customers can only purchase

 

 

09400SB2391ham001 - 16 - LRB094 15742 RLC 57326 a

1     small "convenience packages" of "targeted methamphetamine
2     precursors".
3         (5) I understand that under Illinois law, customers can
4     only purchase these "convenience packages" if they are 18
5     years of age or older, show identification, and sign a log
6     according to procedures that have been described to me.
7         (6) I understand that under Illinois law, I cannot sell
8     more than one "convenience package" to a single customer in
9     one 24-hour period.
10         (7) I understand that under Illinois law, I cannot sell
11     "targeted methamphetamine precursors" to a person if I know
12     that the person is going to use them to make
13     methamphetamine.
14         (8) I understand that there are a number of ingredients
15     that are used to make the illegal drug methamphetamine,
16     including "targeted methamphetamine precursors" sold in
17     "convenience packages". My employer has shown me a list of
18     these various ingredients, and I have reviewed the list.
19         (9) I understand that there are certain procedures that
20     I should follow if I suspect that a store customer is
21     purchasing "targeted methamphetamine precursors" or other
22     products for the purpose of manufacturing methamphetamine.
23     These procedures have been described to me, and I
24     understand them.
25     (c) A certification form of the type described in
26 subsection (b) of this Section may be signed with a handwritten
27 signature or an electronic signature that includes a unique
28 identifier for each employee. The certification shall be
29 retained by the retail distributor for each sales employee for
30 the duration of his or her employment and for at least 30 days
31 following the end of his or her employment. Any such form shall
32 be made available for inspection and copying by any law
33 enforcement officer upon request of that officer. These records
34 may be kept in electronic format if they include all the

 

 

09400SB2391ham001 - 17 - LRB094 15742 RLC 57326 a

1 information specified in this Section in a manner that is
2 readily retrievable and reproducible in hard-copy format.
3     (d) The Office of the Illinois Attorney General shall make
4 available to retail distributors the list of methamphetamine
5 ingredients referred to in subsection (b) of this Section.
6     (e) The training requirements set forth in this Section
7 apply to the distribution of convenience packages away from
8 pharmacy counters as set forth in Section 30 of this Act but do
9 not apply to the distribution of targeted methamphetamine
10 precursors through a pharmacy as set forth in Section 25 of
11 this Act.
12 (Source: P.A. 94-694, eff. 1-15-06.)
 
13     (720 ILCS 648/60 new)
14     Sec. 60. Severability. The provisions of this Act are
15 severable under Section 1.31 of the Statute on Statutes.
 
16     Section 97. Severability. The provisions of this Act are
17 severable under Section 1.31 of the Statute on Statutes.".